SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0001193125-24-009344
Filing Date
2024-01-18
Accepted
2024-01-17 17:48:59
Documents
8
Group Members
HAWAII MERGER SUB, INC.MERCK & CO., INC.

Document Format Files

Seq Description Document Type Size
1 SC 13D d658382dsc13d.htm SC 13D 107808
2 EX-99.2 d658382dex992.htm EX-99.2 25362
3 EX-99.3 d658382dex993.htm EX-99.3 14083
4 EX-99.4 d658382dex994.htm EX-99.4 15465
5 EX-99.5 d658382dex995.htm EX-99.5 19119
6 EX-99.6 d658382dex996.htm EX-99.6 6107
7 GRAPHIC g658382dsp1.jpg GRAPHIC 2577
8 GRAPHIC g658382dsp5.jpg GRAPHIC 4459
  Complete submission text file 0001193125-24-009344.txt   199924
Mailing Address ONE MERCK DR PO BOX 100 WS3AB-05 WHITEHOUSE STATION NJ 08889-0100
Business Address ONE MERCK DR P O BOX 100 WHITEHOUSE STATION NJ 08889-0100 9084231688
MERCK SHARP & DOHME LLC (Filed by) CIK: 0000064978 (see all company filings)

IRS No.: 221109110 | State of Incorp.: NJ | Fiscal Year End: 1231
Type: SC 13D
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 611 GATEWAY BOULEVARD, SUITE 400 SOUTH SAN FRANCISCO CA 94080
Business Address 611 GATEWAY BOULEVARD, SUITE 400 SOUTH SAN FRANCISCO CA 94080 (650) 443-7400
Harpoon Therapeutics, Inc. (Subject) CIK: 0001708493 (see all company filings)

IRS No.: 473458693 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-90935 | Film No.: 24539538
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)